PCV20

20-valent pneumococcal conjugate vaccine · Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PCV20, covering 2025-05-18 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial [Phase 2]

See pricing